Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma. Sam J, Leclercq-Cohen G, Gebhardt S, Surowka M, et al. Blood 2025 Aug 1:blood.2025028863. doi: 10.1182/blood.2025028863.

Read + Share

Amedeo Smart

Independent Medical Education

Sam J, Leclercq-Cohen G, Gebhardt S, Surowka M, et al. Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma. Blood 2025 Aug 1:blood.2025028863. doi: 10.1182/blood.2025028863.
PMID: 40749164